Anti-TPBG (clone A1)-VC-MMAD ADC

• Description:

  This ADC product is comprised of an anti-TPBG monoclonal antibody (clone A1) conjugated via a VC linker to MMAD. The MMAD is targeted to TPBG-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.

• Format:

  Solution

• Shipping Conditions:

  Ice Packs

• Storage Conditions:

  -20°C

• CAS Number:

  9007-83-4